Listen

Description

Barbara Pahud, a native from Mexico City, completed her pediatric residency training at the Infants and Children's Hospital of Brooklyn (Maimonides Medical Center). In 2006 she worked as a postdoctoral fellow at Stanford-Lucile Packard Children's Hospital (LPCH) Vaccine Program and in 2007 started subspecialty training in Pediatric Infectious Diseases at the University of California, San Francisco. In 2008 she was selected for the Vaccine Safety Fellowship Program offered in coordination with the Clinical Immunization Safety Assessment (CISA) Network sponsored by the Immunization Safety Office (ISO) at the Centers for Disease Control and Prevention (CDC). As a vaccine safety fellow during the H1N1 pandemic, she was actively involved in surveillance studies to monitor the safety of H1N1 vaccines.

She joined the Division of Infectious Diseases at Children's Mercy Hospital in 2011. She is currently Associate Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine and The University of Kansas Medical Center, and a faculty member in the Section of Infectious Diseases at Children's Mercy Hospital in Kansas City. Currently she is the Director of Research for the Infectious Diseases Division at Children's Mercy Hospital and the Director of the Kansas City IDEA state Pediatric Clinical Trials Network (ISPCTN) also funded by NIH. She is an active investigator for the CDC's New Vaccine Surveillance Network (NVSN), and a principal investigator in multiple industry-sponsored clinical trials involving drugs and vaccines for children.

Her research focus is clinical trials, vaccine safety, immunization implementation, vaccine education and promotion of research in underserved areas. She is currently a member of the COVID-19 Prevention Network (CoVPN), formed by the National Institute of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health to respond to the global pandemic. As a part of this network, Dr. Pahud is helping address the pressing need for vaccines against SARS-CoV-2 by conducting Phase 3 efficacy trials for COVID-19 vaccines in adults and children. Finally, Dr. Pahud serves as an advisory board member for the advisory committee for childhood vaccines (ACCV) that advises and makes recommendations to the Secretary of Health and Human Services.

Join Dr. Michelle and Dr. Barbara as they talk about:

Mentioned In This Episode

Connect